Re: Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study.

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70323-3 ◽

2007 ◽

Vol 2007 ◽

pp. 74-76

Author(s):

J.T. Thigpen

Keyword(s):

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Relationship between ERCC1 polymorphisms, disease progression, and survivalin GOG0182, a Gynecologic Oncology Group phase III trial of platinum-based chemotherapy in women with advanced stage epithelial ovarian or primary peritoneal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5540 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5540-5540

Author(s):

T. C. Krivak ◽

K. M. Darcy ◽

C. Tian ◽

M. A. Bookman ◽

B. A. Baysal ◽

...

Keyword(s):

Disease Progression ◽

Gynecologic Oncology ◽

Phase Iii ◽

Advanced Stage ◽

Oncology Group ◽

Phase Iii Trial ◽

Peritoneal Cancer ◽

Platinum Based Chemotherapy

Faculty Opinions recommendation of Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8972962.9534062 ◽

2011 ◽

Author(s):

Lee-May Chen

Keyword(s):

Gynecologic Oncology ◽

Low Risk ◽

Phase Iii ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Phase Iii Trial ◽

A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.09.032 ◽

2006 ◽

Vol 100 (3) ◽

pp. 586-590 ◽

Cited By ~ 20

Author(s):

Allan Covens ◽

John Blessing ◽

David Bender ◽

Robert Mannel ◽

Mark Morgan

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Peritoneal Cancer ◽

Platinum Sensitive

Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.007 ◽

2007 ◽

Vol 105 (1) ◽

pp. 280-281

Author(s):

J BELL

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

The Women s Oncology Review ◽

10.3109/14733400412331312594 ◽

2004 ◽

Vol 4 (3) ◽

pp. 205-207

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.014 ◽

2009 ◽

Vol 112 (3) ◽

pp. 543-552 ◽

Cited By ~ 139

Author(s):

Howard D. Homesley ◽

Virginia Filiaci ◽

Susan K. Gibbons ◽

Harry J. Long ◽

David Cella ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.10.071 ◽

2010 ◽

Vol 116 (3) ◽

pp. 332-334 ◽

Cited By ~ 18

Author(s):

Thomas F. Rocereto ◽

William E. Brady ◽

Mark S. Shahin ◽

James S. Hoffman ◽

Laurie Small ◽

...

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.12.057 ◽

2012 ◽

Vol 125 ◽

pp. S24-S25 ◽

Cited By ~ 3

Author(s):

L. Landrum ◽

J. Java ◽

C. Mathews ◽

G. Lanneau ◽

L. Copeland ◽

...

Keyword(s):

Ovarian Cancer ◽

Prognostic Factors ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽